Table 1.
Baseline characteristics of the enrolled patients (N = 347).
Table 2.
Acute kidney injury in patients with HCC who underwent TACE.
Table 3.
Risk factors for acute kidney injury in patients with HCC who underwent TACE a.
Fig 1.
Overall survival of the enrolled patients.
Table 4.
Risk factors for overall survival in patients with HCC who underwent TACE.
Fig 2.
Overall survival according to risk factors in patients with HCC who underwent TACE: (A) serum albumin level, (B) tumor location: unilobar vs bilobar, (C) BCLC stage, and (D) AKI stage.
*Abbreviation: HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization; BCLC, Barcellona Clinic Liver Cancer; AKI, acute kidney injury.